Hyperkalemia Recruiting Phase 4 Trials for Sodium zirconium cyclosilicate (DB14048)

Also known as: Hyperkalemia (HK) / Hyperkalaemia / Hyperpotassaemia / Hyperpotassemia / Potassium overload / Potassium [K] excess

IndicationStatusPhase
DBCOND0003949 (Hyperkalemia)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04676646Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving SpironolactoneTreatment
NCT05347693Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge StudyTreatment
NCT05535920A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic HyperkalemiaPrevention